Arlene Gutman, BSC (HONS) Ireland is one of few high-income countries with an established national perinatal mortality audit that is published in an annual report. This study reviewed the national perinatal mortality
HARVEY J. KLIMAN, MD, PHD After bereavement support following a pregnancy loss, the next most important step is todetermine the cause of the loss. This can both start the healing
MARGARET MURPHY, DN, MSC, BSC, RM, RGN, IBCLC Planning a pregnancy after the death of baby is complex with many competing emotions. Couples’ experiences of their decision-making processes, with various
Dexter J L Hayes, MRES, BSC (HONS) This presentation will describe the development of a core outcome set in reduced fetal movement research and will cover what core outcome sets
JAMES A. NICHOLSON, MD, MSCE his session will discuss the increased risk, in the USA, of term stillbirth in patients of African heritage, and will link that reality with available
ANNE E. BRISEDINE, DRPH, MPH, CHES This Presentation will explore the patterns of stillbirth across maternal race, ethnicity, and age in recent US data. Gaps in research and opportunities to
JANE WARLAND, RN, RN, DIPAPPL SC (NURS), GRAD CERT ED (UNI TEACH) This presentation will first outline how and why the Prenabelt 2 was developed. Then the study methodology will
PROFESSOR PETER STONE: DM (BRIST.), BSC, MBCHB, DIPOBST, FRANZCOG, FRCOG, DDU, CMFM Late unexplained stillbirth is associated with maternal going to sleep position. MRI studies have elucidated the physiological effects
Yolanda Marie Archibald, MD Lipoprotein(a) or Lp(a) is a prothrombotic low density cholesterol that has been underappreciated by clinicians and therefore has not been given much attention until recently. Lp(a)
Barbara Toppin, MD After years of treating pregnancy loss and following long term patients with known thrombophila, a secondary benefit of improved cardiovascular health is emerging. This talk seeks to
Suzan Carmichael, PHD, MS In this presentation, we will discuss different approaches to prediction of pregnancy complications, including discovery of exosomal biomarkers. Dr. Louise Laurent, is a Professor and the
Louise Laurent, MD, PHD In this presentation, we will discuss different approaches to prediction of pregnancy complications, including discovery of exosomal biomarkers. Dr. Louise Laurent, is a Professor and the
